BCL2 and Parkinson disease: Exposure to mild hyperbaric oxygen activates oxidative metabolism in dopaminergic neurons in the substantia nigra, which inhibits the reduction in dopaminergic neurons and oxidative stress and protects against Bax/Bcl-2-mediated apoptosis, thereby resulting in an attenuation of Parkinson’s disease [51,52].